Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy

Histone deacetylase inhibitors (HDACi) have been approved and achieved success in hematologic malignancies. But its application in solid tumors still confronts big challenges and is hampered by low treatment efficacy. Nanotechnology has been widely applied in cancer therapy, and nanomedicine could i...

Full description

Saved in:
Bibliographic Details
Published in:Front Cell Dev Biol
Main Authors: Tu, Bin, Zhang, Meng, Liu, Tuanbing, Huang, Yongzhuo
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Cell and Developmental Biology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284110/
https://ncbi.nlm.nih.gov/pubmed/32582697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00400
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items